<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>横浜中央病院がん種別化学療法レジメン一覧 - 横浜中央病院</title>
	<atom:link href="https://yokohama.jcho.go.jp/introduction/various/%e3%81%8c%e3%82%93%e7%a8%ae%e5%88%a5%e5%8c%96%e5%ad%a6%e7%99%82%e6%b3%95/feed" rel="self" type="application/rss+xml" />
	<link>https://yokohama.jcho.go.jp</link>
	<description>地域医療機能推進機構（JCHO)横浜中央病院は、「温かい心と気配りの医療 」の基本理念のもとに地域社会に溶け込み保健・医療・福祉に貢献します。様々な健診・ドックも取り扱っております。看護学校も併設しております。（横浜市中区山下町）</description>
	<lastBuildDate>Mon, 06 Apr 2026 01:06:17 +0000</lastBuildDate>
	<language>ja</language>
		<sy:updatePeriod>hourly</sy:updatePeriod>
		<sy:updateFrequency>1</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.4.1</generator>
	<item>
		<title>すい臓がん</title>
		<link>https://yokohama.jcho.go.jp/introduction/various/%e3%81%8c%e3%82%93%e7%a8%ae%e5%88%a5%e5%8c%96%e5%ad%a6%e7%99%82%e6%b3%95/%e3%81%99%e3%81%84%e8%87%93%e3%81%8c%e3%82%93/</link>
		<pubDate>Fri, 16 May 2025 02:08:46 +0000</pubDate>
				<category><![CDATA[がん種別化学療法レジメン一覧]]></category>

		<guid isPermaLink="false">https://yokohama.jcho.go.jp/?p=14230</guid>
		<description><![CDATA[すい臓がん GEM GS mFOLFIRINOX nab-PTX+GEM nal+IRI+5-FU+l-LV 一覧に戻る]]></description>
				<content:encoded><![CDATA[<h2>すい臓がん</h2>
<ul style="margin-left: 3em">
	<li><a href="/wp-content/uploads/2025/05/GEM.pdf" target="_blank" rel="noopener">GEM</a></li>
	<li><a href="/wp-content/uploads/2025/05/GS.pdf" target="_blank" rel="noopener">GS</a></li>
	<li><a href="/wp-content/uploads/2025/05/mFOLFIRINOX.pdf" target="_blank" rel="noopener">mFOLFIRINOX</a></li>
	<li><a href="/wp-content/uploads/2025/05/nab-PTXGEM.pdf" target="_blank" rel="noopener">nab-PTX+GEM</a></li>
	<li><a href="/wp-content/uploads/2025/05/nalIRI5-FUl-LV.pdf" target="_blank" rel="noopener">nal+IRI+5-FU+l-LV</a></li>
	</ul>
<p><li><a href="https://yokohama.jcho.go.jp/?p=14218">一覧に戻る</a></li></p>]]></content:encoded>
			<wfw:commentRss>https://yokohama.jcho.go.jp/introduction/various/%e3%81%8c%e3%82%93%e7%a8%ae%e5%88%a5%e5%8c%96%e5%ad%a6%e7%99%82%e6%b3%95/%e3%81%99%e3%81%84%e8%87%93%e3%81%8c%e3%82%93/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>大腸がん</title>
		<link>https://yokohama.jcho.go.jp/introduction/various/%e3%81%8c%e3%82%93%e7%a8%ae%e5%88%a5%e5%8c%96%e5%ad%a6%e7%99%82%e6%b3%95/%e5%a4%a7%e8%85%b8%e3%81%8c%e3%82%93/</link>
		<pubDate>Fri, 16 May 2025 02:16:04 +0000</pubDate>
				<category><![CDATA[がん種別化学療法レジメン一覧]]></category>

		<guid isPermaLink="false">https://yokohama.jcho.go.jp/?p=14281</guid>
		<description><![CDATA[大腸がん AFL+FOLFIRI BEV+Capecitabine BEV+CAPOX BEV+CPT11 BEV+FOLFIRI BEV+FOLFOXIRI Bev+FTD・TPI BEV+IRIS(SIRB) BEV [&#8230;]]]></description>
				<content:encoded><![CDATA[<h2>大腸がん</h2>
<ul style="margin-left: 3em">
	<li><a href="/wp-content/uploads/2025/05/AFLFOLFIRI.pdf" target="_blank" rel="noopener">AFL+FOLFIRI</a></li>
	<li><a href="/wp-content/uploads/2025/06/BEVCapecitabine.pdf" target="_blank" rel="noopener">BEV+Capecitabine</a></li>
	<li><a href="/wp-content/uploads/2025/06/BEVCAPOX.pdf" target="_blank" rel="noopener">BEV+CAPOX</a></li>
	<li><a href="/wp-content/uploads/2025/05/BEVCPT11.pdf" target="_blank" rel="noopener">BEV+CPT11</a></li>
	<li><a href="/wp-content/uploads/2025/05/BEVFOLFIRI.pdf" target="_blank" rel="noopener">BEV+FOLFIRI</a></li>
<li><a href="/wp-content/uploads/2025/05/BEVFOLFOXIRI.pdf" target="_blank" rel="noopener">BEV+FOLFOXIRI</a></li>
<li><a href="/wp-content/uploads/2025/05/BevFTD・TPI.pdf" target="_blank" rel="noopener">Bev+FTD・TPI</a></li>
<li><a href="/wp-content/uploads/2025/05/BEVIRISSIRB.pdf" target="_blank" rel="noopener">BEV+IRIS(SIRB)</a></li>
<li><a href="/wp-content/uploads/2025/05/BEVIRIS.pdf" target="_blank" rel="noopener">BEV+IRIS</a></li>
<li><a href="/wp-content/uploads/2025/05/BEVmFOLFOX6.pdf" target="_blank" rel="noopener">BEV+mFOLFOX6</a></li>
<li><a href="/wp-content/uploads/2025/05/BEVRPMI.pdf" target="_blank" rel="noopener">BEV+RPMI</a></li>
<li><a href="/wp-content/uploads/2025/05/BEVSOX.pdf" target="_blank" rel="noopener">BEV+SOX</a></li>
<li><a href="/wp-content/uploads/2025/06/CAPOX.pdf" target="_blank" rel="noopener">CAPOX</a></li>
<li><a href="/wp-content/uploads/2025/05/CetBiweekly.pdf" target="_blank" rel="noopener">Cet(Biweekly)</a></li>
<li><a href="/wp-content/uploads/2025/05/CetWeekly.pdf" target="_blank" rel="noopener">Cet(Weekly)</a></li>
<li><a href="/wp-content/uploads/2025/05/CetCPT11Biweekly.pdf" target="_blank" rel="noopener">Cet+CPT11(Biweekly)</a></li>
<li><a href="/wp-content/uploads/2025/05/CetCPT11Weekly.pdf" target="_blank" rel="noopener">Cet+CPT11(Weekly)</a></li>
<li><a href="/wp-content/uploads/2025/05/CETENCO.pdf" target="_blank" rel="noopener">CET+ENCO</a></li>
<li><a href="/wp-content/uploads/2025/05/CETENCOBINI.pdf" target="_blank" rel="noopener">CET+ENCO+BINI</a></li>
<li><a href="/wp-content/uploads/2025/05/CetFOLFIRIBiweekly.pdf" target="_blank" rel="noopener">Cet+FOLFIRI(Biweekly)</a></li>
<li><a href="/wp-content/uploads/2025/05/CetFOLFIRIWeekly.pdf" target="_blank" rel="noopener">Cet+FOLFIRI(Weekly)</a></li>
<li><a href="/wp-content/uploads/2025/05/CetmFOLFOXBiweekly.pdf" target="_blank" rel="noopener">Cet+mFOLFOX(Biweekly)</a></li>
<li><a href="/wp-content/uploads/2025/05/CetmFOLFOXWeekly.pdf" target="_blank" rel="noopener">Cet+mFOLFOX(Weekly)</a></li>
<li><a href="/wp-content/uploads/2025/05/CPT11A法.pdf" target="_blank" rel="noopener">CPT11(A法)</a></li>
<li><a href="/wp-content/uploads/2025/05/CPT11B法.pdf" target="_blank" rel="noopener">CPT11(B法)</a></li>
<li><a href="/wp-content/uploads/2025/05/FOLFIRI.pdf" target="_blank" rel="noopener">FOLFIRI</a></li>
<li><a href="/wp-content/uploads/2025/05/FOLFOX4.pdf" target="_blank" rel="noopener">FOLFOX4</a></li>
<li><a href="/wp-content/uploads/2025/05/FTD・TPI.pdf" target="_blank" rel="noopener">FTD・TPI</a></li>
<li><a href="/wp-content/uploads/2025/05/LV5FU2.pdf" target="_blank" rel="noopener">LV5FU2</a></li>
<li><a href="/wp-content/uploads/2025/05/mFOLFOX6.pdf" target="_blank" rel="noopener">mFOLFOX6</a></li>
<li><a href="/wp-content/uploads/2025/05/Pani.pdf" target="_blank" rel="noopener">Pani</a></li>
<li><a href="/wp-content/uploads/2025/05/PaniCPT11.pdf" target="_blank" rel="noopener">Pani+CPT11</a></li>
<li><a href="/wp-content/uploads/2025/05/PaniFOLFIRI.pdf" target="_blank" rel="noopener">Pani+FOLFIRI</a></li>
<li><a href="/wp-content/uploads/2025/05/PanimFOLFOX.pdf" target="_blank" rel="noopener">Pani+mFOLFOX</a></li>
<li><a href="/wp-content/uploads/2025/05/Pemb.pdf" target="_blank" rel="noopener">Pemb</a></li>
<li><a href="/wp-content/uploads/2025/05/PERTmab.pdf" target="_blank" rel="noopener">PER+Tmab</a></li>
<li><a href="/wp-content/uploads/2025/05/RAMFOLFIRI.pdf" target="_blank" rel="noopener">RAM+FOLFIRI</a></li>
<li><a href="/wp-content/uploads/2025/05/RPMI.pdf" target="_blank" rel="noopener">RPMI</a></li>
<li><a href="/wp-content/uploads/2025/05/S-1.pdf" target="_blank" rel="noopener">S-1</a></li>
<li><a href="/wp-content/uploads/2025/05/S1CPT11IRIS.pdf" target="_blank" rel="noopener">S1+CPT11(IRIS)</a></li>
<li><a href="/wp-content/uploads/2025/05/S1CPT11SIR.pdf" target="_blank" rel="noopener">S1+CPT11(SIR)</a></li>
<li><a href="/wp-content/uploads/2025/05/sLV5FU2.pdf" target="_blank" rel="noopener">sLV5FU2</a></li>
<li><a href="/wp-content/uploads/2025/05/SOX.pdf" target="_blank" rel="noopener">SOX</a></li>
<li><a href="/wp-content/uploads/2025/05/UFT・UZEL.pdf" target="_blank" rel="noopener">UFT・UZEL</a></li>
<li><a href="/wp-content/uploads/2025/06/カペシタビン.pdf" target="_blank" rel="noopener">カペシタビン</a></li>
<li><a href="/wp-content/uploads/2025/05/レゴラフェニブ.pdf" target="_blank" rel="noopener">レゴラフェニブ</a></li>
	</ul>
<p><li><a href="https://yokohama.jcho.go.jp/?p=14218">一覧に戻る</a></li></p>]]></content:encoded>
			<wfw:commentRss>https://yokohama.jcho.go.jp/introduction/various/%e3%81%8c%e3%82%93%e7%a8%ae%e5%88%a5%e5%8c%96%e5%ad%a6%e7%99%82%e6%b3%95/%e5%a4%a7%e8%85%b8%e3%81%8c%e3%82%93/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>胃がん</title>
		<link>https://yokohama.jcho.go.jp/introduction/various/%e3%81%8c%e3%82%93%e7%a8%ae%e5%88%a5%e5%8c%96%e5%ad%a6%e7%99%82%e6%b3%95/%e8%83%83%e3%81%8c%e3%82%93/</link>
		<pubDate>Fri, 16 May 2025 02:16:31 +0000</pubDate>
				<category><![CDATA[がん種別化学療法レジメン一覧]]></category>

		<guid isPermaLink="false">https://yokohama.jcho.go.jp/?p=14316</guid>
		<description><![CDATA[胃がん CAPOX CPT-11（A法） CPT-11（B法） DCF DCS FTD・TPI ｍFOLFOX Nivo(2w) Nivo(4w) Nivo+CAPOX Nivo+mFOLFOX Nivo+SOX RAM [&#8230;]]]></description>
				<content:encoded><![CDATA[<h2>胃がん</h2>
<ul style="margin-left: 3em;">
 	<li><a href="/wp-content/uploads/2025/05/CAPOX-1.pdf" target="_blank" rel="noopener">CAPOX</a></li>
 	<li><a href="/wp-content/uploads/2025/05/CPT-11（A法）.pdf" target="_blank" rel="noopener">CPT-11（A法）</a></li>
 	<li><a href="/wp-content/uploads/2025/05/CPT-11（B法）.pdf" target="_blank" rel="noopener">CPT-11（B法）</a></li>
 	<li><a href="/wp-content/uploads/2025/05/DCF.pdf" target="_blank" rel="noopener">DCF</a></li>
 	<li><a href="/wp-content/uploads/2025/05/DCS.pdf" target="_blank" rel="noopener">DCS</a></li>
 	<li><a href="/wp-content/uploads/2025/05/TFDTPI.pdf" target="_blank" rel="noopener">FTD・TPI</a></li>
 	<li><a href="/wp-content/uploads/2025/05/ｍFOLFOX.pdf" target="_blank" rel="noopener">ｍFOLFOX</a></li>
 	<li><a href="/wp-content/uploads/2025/05/Nivo2w.pdf" target="_blank" rel="noopener">Nivo(2w)</a></li>
 	<li><a href="/wp-content/uploads/2025/05/Nivo4w.pdf" target="_blank" rel="noopener">Nivo(4w)</a></li>
 	<li><a href="/wp-content/uploads/2025/05/NivoCAPOX.pdf" target="_blank" rel="noopener">Nivo+CAPOX</a></li>
 	<li><a href="/wp-content/uploads/2025/05/NivomFOLFOX.pdf" target="_blank" rel="noopener">Nivo+mFOLFOX</a></li>
 	<li><a href="/wp-content/uploads/2025/05/NivoSOX.pdf" target="_blank" rel="noopener">Nivo+SOX</a></li>
 	<li><a href="/wp-content/uploads/2025/05/RAM.pdf" target="_blank" rel="noopener">RAM</a></li>
 	<li><a href="/wp-content/uploads/2025/05/RAMnabPTX.pdf" target="_blank" rel="noopener">RAM+nabPTX</a></li>
 	<li><a href="/wp-content/uploads/2025/05/RAMPTX.pdf" target="_blank" rel="noopener">RAM+PTX</a></li>
 	<li><a href="/wp-content/uploads/2025/05/S-1-1.pdf" target="_blank" rel="noopener">S-1</a></li>
 	<li><a href="/wp-content/uploads/2025/05/S-1CDDP.pdf" target="_blank" rel="noopener">S-1+CDDP</a></li>
 	<li><a href="/wp-content/uploads/2025/05/S-1DTX.pdf" target="_blank" rel="noopener">S-1+DTX</a></li>
 	<li><a href="/wp-content/uploads/2025/05/SOX-1.pdf" target="_blank" rel="noopener">SOX</a></li>
 	<li><a href="/wp-content/uploads/2025/05/T-Dxd.pdf" target="_blank" rel="noopener">T-Dxd</a></li>
 	<li><a href="/wp-content/uploads/2025/05/TmabCAPOX.pdf" target="_blank" rel="noopener">Tmab+CAPOX</a></li>
 	<li><a href="/wp-content/uploads/2025/05/TmabSOX.pdf" target="_blank" rel="noopener">Tmab+SOX</a></li>
 	<li><a href="/wp-content/uploads/2025/05/TmabXP.pdf" target="_blank" rel="noopener">Tmab+XP</a></li>
 	<li><a href="/wp-content/uploads/2025/05/triweekly-nabPTX.pdf" target="_blank" rel="noopener">triweekly nabPTX</a></li>
 	<li><a href="/wp-content/uploads/2025/05/weekly-nabPTX.pdf" target="_blank" rel="noopener">weekly nabPTX</a></li>
 	<li><a href="/wp-content/uploads/2025/05/weeklyPTX.pdf" target="_blank" rel="noopener">weeklyPTX</a></li>
 	<li><a href="/wp-content/uploads/2025/05/ｿﾞﾙﾍﾞﾂｷｼﾏﾌﾞCAPOX.pdf" target="_blank" rel="noopener">ｿﾞﾙﾍﾞﾂｷｼﾏﾌﾞ+CAPOX</a></li>
 	<li><a href="/wp-content/uploads/2025/05/ｿﾞﾙﾍﾞﾂｷｼﾏﾌﾞmFOLFOX6.pdf" target="_blank" rel="noopener">ｿﾞﾙﾍﾞﾂｷｼﾏﾌﾞ+mFOLFOX6</a></li>
</ul>
<p><li><a href="https://yokohama.jcho.go.jp/?p=14218">一覧に戻る</a></li></p>
</ul>]]></content:encoded>
			<wfw:commentRss>https://yokohama.jcho.go.jp/introduction/various/%e3%81%8c%e3%82%93%e7%a8%ae%e5%88%a5%e5%8c%96%e5%ad%a6%e7%99%82%e6%b3%95/%e8%83%83%e3%81%8c%e3%82%93/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>食道がん</title>
		<link>https://yokohama.jcho.go.jp/introduction/various/%e3%81%8c%e3%82%93%e7%a8%ae%e5%88%a5%e5%8c%96%e5%ad%a6%e7%99%82%e6%b3%95/%e9%a3%9f%e9%81%93%e3%81%8c%e3%82%93/</link>
		<pubDate>Fri, 16 May 2025 02:16:53 +0000</pubDate>
				<category><![CDATA[がん種別化学療法レジメン一覧]]></category>

		<guid isPermaLink="false">https://yokohama.jcho.go.jp/?p=14329</guid>
		<description><![CDATA[食道がん 5-FU+CDGP DCF DTX+CDGP Triweekly DTX 高用量5-FU+CDDP 低用量5-FU+CDDP 一覧に戻る]]></description>
				<content:encoded><![CDATA[<h2>食道がん</h2>
<ul style="margin-left: 3em">
<li><a href="/wp-content/uploads/2025/05/5-FUCDGP.pdf" target="_blank" rel="noopener">5-FU+CDGP</a></li>
<li><a href="/wp-content/uploads/2025/05/DCF-1.pdf" target="_blank" rel="noopener">DCF</a></li>
<li><a href="/wp-content/uploads/2025/05/DTXCDGP.pdf" target="_blank" rel="noopener">DTX+CDGP</a></li>
<li><a href="/wp-content/uploads/2025/05/Triweekly-　DTX.pdf" target="_blank" rel="noopener">Triweekly DTX</a></li>
<li><a href="/wp-content/uploads/2025/05/高用量5-FUCDDP.pdf" target="_blank" rel="noopener">高用量5-FU+CDDP</a></li>
<li><a href="/wp-content/uploads/2025/05/低用量5-FUCDDP.pdf" target="_blank" rel="noopener">低用量5-FU+CDDP</a></li>
	</ul>
<p><li><a href="https://yokohama.jcho.go.jp/?p=14218">一覧に戻る</a></li></p>]]></content:encoded>
			<wfw:commentRss>https://yokohama.jcho.go.jp/introduction/various/%e3%81%8c%e3%82%93%e7%a8%ae%e5%88%a5%e5%8c%96%e5%ad%a6%e7%99%82%e6%b3%95/%e9%a3%9f%e9%81%93%e3%81%8c%e3%82%93/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>肝細胞癌</title>
		<link>https://yokohama.jcho.go.jp/introduction/various/%e3%81%8c%e3%82%93%e7%a8%ae%e5%88%a5%e5%8c%96%e5%ad%a6%e7%99%82%e6%b3%95/%e8%82%9d%e7%b4%b0%e8%83%9e%e7%99%8c/</link>
		<pubDate>Fri, 16 May 2025 02:18:19 +0000</pubDate>
				<category><![CDATA[がん種別化学療法レジメン一覧]]></category>

		<guid isPermaLink="false">https://yokohama.jcho.go.jp/?p=14339</guid>
		<description><![CDATA[肝細胞癌 Atezo+Bev Ram デュルマルマブ デュルマルマブ+トレメリムマブ 一覧に戻る]]></description>
				<content:encoded><![CDATA[<h2>肝細胞癌</h2>
<ul style="margin-left: 3em">
<li><a href="/wp-content/uploads/2025/05/AtezoBev.pdf" target="_blank" rel="noopener">Atezo+Bev</a></li>
<li><a href="/wp-content/uploads/2025/05/Ram.pdf" target="_blank" rel="noopener">Ram</a></li>
<li><a href="/wp-content/uploads/2025/05/デュルマルマブ.pdf" target="_blank" rel="noopener">デュルマルマブ</a></li>
<li><a href="/wp-content/uploads/2025/05/デュルマルマブトレメリムマブ.pdf" target="_blank" rel="noopener">デュルマルマブ+トレメリムマブ</a></li>
	</ul>
<p><li><a href="https://yokohama.jcho.go.jp/?p=14218">一覧に戻る</a></li></p>]]></content:encoded>
			<wfw:commentRss>https://yokohama.jcho.go.jp/introduction/various/%e3%81%8c%e3%82%93%e7%a8%ae%e5%88%a5%e5%8c%96%e5%ad%a6%e7%99%82%e6%b3%95/%e8%82%9d%e7%b4%b0%e8%83%9e%e7%99%8c/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>胆道がん</title>
		<link>https://yokohama.jcho.go.jp/introduction/various/%e3%81%8c%e3%82%93%e7%a8%ae%e5%88%a5%e5%8c%96%e5%ad%a6%e7%99%82%e6%b3%95/%e8%83%86%e9%81%93%e3%81%8c%e3%82%93/</link>
		<pubDate>Fri, 16 May 2025 02:17:14 +0000</pubDate>
				<category><![CDATA[がん種別化学療法レジメン一覧]]></category>

		<guid isPermaLink="false">https://yokohama.jcho.go.jp/?p=14347</guid>
		<description><![CDATA[胆道がん GC GCS GEM GS デュルマルマブ デュルマルマブ+GC 一覧に戻る]]></description>
				<content:encoded><![CDATA[<h2>胆道がん</h2>
<ul style="margin-left: 3em">
<li><a href="/wp-content/uploads/2025/05/GC.pdf" target="_blank" rel="noopener">GC</a></li>
<li><a href="/wp-content/uploads/2025/05/GCS.pdf" target="_blank" rel="noopener">GCS</a></li>
<li><a href="/wp-content/uploads/2025/05/GEM-1.pdf" target="_blank" rel="noopener">GEM</a></li>
<li><a href="/wp-content/uploads/2025/05/GS-1.pdf" target="_blank" rel="noopener">GS</a></li>
<li><a href="/wp-content/uploads/2025/05/デュルマルマブ-1.pdf" target="_blank" rel="noopener">デュルマルマブ</a></li>
<li><a href="/wp-content/uploads/2025/05/デュルマルマブGC.pdf" target="_blank" rel="noopener">デュルマルマブ+GC</a></li>
	</ul>
<p><li><a href="https://yokohama.jcho.go.jp/?p=14218">一覧に戻る</a></li></p>]]></content:encoded>
			<wfw:commentRss>https://yokohama.jcho.go.jp/introduction/various/%e3%81%8c%e3%82%93%e7%a8%ae%e5%88%a5%e5%8c%96%e5%ad%a6%e7%99%82%e6%b3%95/%e8%83%86%e9%81%93%e3%81%8c%e3%82%93/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>乳がん</title>
		<link>https://yokohama.jcho.go.jp/introduction/various/%e3%81%8c%e3%82%93%e7%a8%ae%e5%88%a5%e5%8c%96%e5%ad%a6%e7%99%82%e6%b3%95/%e4%b9%b3%e3%81%8c%e3%82%93/</link>
		<pubDate>Fri, 16 May 2025 02:17:33 +0000</pubDate>
				<category><![CDATA[がん種別化学療法レジメン一覧]]></category>

		<guid isPermaLink="false">https://yokohama.jcho.go.jp/?p=14357</guid>
		<description><![CDATA[乳がん Capecitabine Eribulin PER+Tmab+DTX S-1 Tmab Triweekly　DTX VNB Weekly PTX 一覧に戻る]]></description>
				<content:encoded><![CDATA[<h2>乳がん</h2>
<ul style="margin-left: 3em">
<li><a href="/wp-content/uploads/2025/05/BevPTX.pdf"_blank" rel="noopener">Bev+PTX</a></li>
<li><a href="/wp-content/uploads/2025/05/Capecitabine.pdf"_blank" rel="noopener">Capecitabine</a></li>
<li><a href="/wp-content/uploads/2025/05/EC.pdf"_blank" rel="noopener">EC</a></li>
<li><a href="/wp-content/uploads/2025/05/Eribulin.pdf"_blank" rel="noopener">Eribulin</a></li>
<li><a href="/wp-content/uploads/2025/05/FEC.pdf"_blank" rel="noopener">FEC</a></li>
<li><a href="/wp-content/uploads/2025/05/PERTmabDTX.pdf"_blank" rel="noopener">PER+Tmab+DTX</a></li>
<li><a href="/wp-content/uploads/2025/05/PERTmabメンテナンス.pdf"_blank" rel="noopener">PER+Tmab(メンテナンス)</a></li>
<li><a href="/wp-content/uploads/2025/05/S-1-2.pdf"_blank" rel="noopener">S-1</a></li>
<li><a href="/wp-content/uploads/2025/05/T-DM1.pdf"_blank" rel="noopener">T-DM1</a></li>
<li><a href="/wp-content/uploads/2025/05/Tmab.pdf"_blank" rel="noopener">Tmab</a></li>
<li><a href="/wp-content/uploads/2025/05/TmabPTX.pdf"_blank" rel="noopener">Tmab+PTX</a></li>
<li><a href="/wp-content/uploads/2025/05/Triweekly　DTX.pdf"_blank" rel="noopener">Triweekly　DTX</a></li>
<li><a href="/wp-content/uploads/2025/05/Triweekly-nab-PTX.pdf"_blank" rel="noopener">Triweekly nab-PTX</a></li>
<li><a href="/wp-content/uploads/2025/05/VNB.pdf"_blank" rel="noopener">VNB</a></li>
<li><a href="/wp-content/uploads/2025/05/VNBTmab.pdf"_blank" rel="noopener">VNB+Tmab</a></li>
<li><a href="/wp-content/uploads/2025/05/Weekly-PTX.pdf"_blank" rel="noopener">Weekly PTX</a></li>
	</ul>
<p><li><a href="https://yokohama.jcho.go.jp/?p=14218">一覧に戻る</a></li></p>]]></content:encoded>
			<wfw:commentRss>https://yokohama.jcho.go.jp/introduction/various/%e3%81%8c%e3%82%93%e7%a8%ae%e5%88%a5%e5%8c%96%e5%ad%a6%e7%99%82%e6%b3%95/%e4%b9%b3%e3%81%8c%e3%82%93/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>肛門管がん</title>
		<link>https://yokohama.jcho.go.jp/introduction/various/%e3%81%8c%e3%82%93%e7%a8%ae%e5%88%a5%e5%8c%96%e5%ad%a6%e7%99%82%e6%b3%95/%e8%82%9b%e9%96%80%e7%ae%a1%e3%81%8c%e3%82%93/</link>
		<pubDate>Fri, 16 May 2025 02:19:36 +0000</pubDate>
				<category><![CDATA[がん種別化学療法レジメン一覧]]></category>

		<guid isPermaLink="false">https://yokohama.jcho.go.jp/?p=14382</guid>
		<description><![CDATA[肛門管がん 5FU+MMC+放射線]]></description>
				<content:encoded><![CDATA[<h2>肛門管がん</h2>
<ul style="margin-left: 3em">
<li><a href="/wp-content/uploads/2025/05/5FUCDDP放射線.pdf"_blank" rel="noopener">5FU+CDDP+放射線</a></li>
<li><a href="/wp-content/uploads/2025/05/5FUMMC放射線.pdf"_blank" rel="noopener">5FU+MMC+放射線</a></li>
<li><a href="/wp-content/uploads/2025/05/CapecitabineMMC放射線.pdf"_blank" rel="noopener">Capecitabine+MMC+放射線</a></li>
	</ul>
<p><li><a href="https://yokohama.jcho.go.jp/?p=14218">一覧に戻る</a></li></p>]]></content:encoded>
			<wfw:commentRss>https://yokohama.jcho.go.jp/introduction/various/%e3%81%8c%e3%82%93%e7%a8%ae%e5%88%a5%e5%8c%96%e5%ad%a6%e7%99%82%e6%b3%95/%e8%82%9b%e9%96%80%e7%ae%a1%e3%81%8c%e3%82%93/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>神経内分泌腫瘍</title>
		<link>https://yokohama.jcho.go.jp/introduction/various/%e3%81%8c%e3%82%93%e7%a8%ae%e5%88%a5%e5%8c%96%e5%ad%a6%e7%99%82%e6%b3%95/%e7%a5%9e%e7%b5%8c%e5%86%85%e5%88%86%e6%b3%8c%e8%85%ab%e7%98%8d/</link>
		<pubDate>Fri, 16 May 2025 02:18:59 +0000</pubDate>
				<category><![CDATA[がん種別化学療法レジメン一覧]]></category>

		<guid isPermaLink="false">https://yokohama.jcho.go.jp/?p=14377</guid>
		<description><![CDATA[神経内分泌腫瘍 CDDP+CPT-11]]></description>
				<content:encoded><![CDATA[<h2>神経内分泌腫瘍</h2>
<ul style="margin-left: 3em">
<li><a href="/wp-content/uploads/2025/05/AMR.pdf"_blank" rel="noopener">AMR</a></li>
<li><a href="/wp-content/uploads/2025/05/CDDPCPT-11.pdf"_blank" rel="noopener">CDDP+CPT-11</a></li>
<li><a href="/wp-content/uploads/2025/05/CDDPETP.pdf"_blank" rel="noopener">CDDP+ETP</a></li>
	</ul>
<p><li><a href="https://yokohama.jcho.go.jp/?p=14218">一覧に戻る</a></li></p>]]></content:encoded>
			<wfw:commentRss>https://yokohama.jcho.go.jp/introduction/various/%e3%81%8c%e3%82%93%e7%a8%ae%e5%88%a5%e5%8c%96%e5%ad%a6%e7%99%82%e6%b3%95/%e7%a5%9e%e7%b5%8c%e5%86%85%e5%88%86%e6%b3%8c%e8%85%ab%e7%98%8d/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>クローン病</title>
		<link>https://yokohama.jcho.go.jp/introduction/various/%e3%81%8c%e3%82%93%e7%a8%ae%e5%88%a5%e5%8c%96%e5%ad%a6%e7%99%82%e6%b3%95/%e3%82%af%e3%83%ad%e3%83%bc%e3%83%b3%e7%97%85/</link>
		<pubDate>Fri, 16 May 2025 02:20:01 +0000</pubDate>
				<category><![CDATA[がん種別化学療法レジメン一覧]]></category>

		<guid isPermaLink="false">https://yokohama.jcho.go.jp/?p=14387</guid>
		<description><![CDATA[クローン病]]></description>
				<content:encoded><![CDATA[<h2>クローン病</h2>
<ul style="margin-left: 3em">
<li><a href="/wp-content/uploads/2025/05/クローン病.pdf"_blank" rel="noopener">クローン病</a></li>
	</ul>
<p><li><a href="https://yokohama.jcho.go.jp/?p=14218">一覧に戻る</a></li></p>]]></content:encoded>
			<wfw:commentRss>https://yokohama.jcho.go.jp/introduction/various/%e3%81%8c%e3%82%93%e7%a8%ae%e5%88%a5%e5%8c%96%e5%ad%a6%e7%99%82%e6%b3%95/%e3%82%af%e3%83%ad%e3%83%bc%e3%83%b3%e7%97%85/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
